{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:32Z","timestamp":1793600792580,"version":"4.5.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jid.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:15:49Z","timestamp":1781126149000},"page":"2350-2352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trials and tribulations of systemic inflammation and cardiovascular risk in psoriasis"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-9455","authenticated-orcid":false,"given":"Ravi","family":"Ramessur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-2661","authenticated-orcid":false,"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.05.002_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005285","article-title":"Two decades of cardiovascular trials with primary surrogate endpoints: 1990-2011","volume":"6","author":"Bikdeli","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jid.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamadermatol.2024.3897","article-title":"Home- vs office-based narrowband UV-B phototherapy for patients with psoriasis: the LITE randomized clinical trial","volume":"160","author":"Gelfand","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.jid.2021.03.024","article-title":"Impact of biological agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"141","author":"Gonz\u00e1lez-Cantero","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jid.2025.03.014","article-title":"Residual inflammation in patients with psoriasis treated with biologic therapy: findings from 3 prospective observational cohorts","volume":"145","author":"Lecumberri","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jid.2026.01.043","article-title":"Impact of deucravacitinib on NLR and other inflammatory biomarkers of cardiovascular risk in psoriasis: posthoc analyses of phase 3 trials","volume":"146","author":"Luo","year":"2026","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.05.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107238","article-title":"Targeting residual inflammatory risk: the next frontier for atherosclerosis treatment and prevention","volume":"153","author":"Ridker","year":"2023","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jid.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamadermatol.2025.2357","article-title":"Emollients to prevent pediatric eczema: A randomized clinical trial","volume":"161","author":"Simpson","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26012066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26012066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:31:50Z","timestamp":1793597510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26012066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022202X26012066"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.05.002","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trials and tribulations of systemic inflammation and cardiovascular risk in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.01.043","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Investigative Dermatology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}